Elevian is developing medicines that promote recovery and regeneration. Our lead program is a recombinant protein for the treatment of stroke during recovery.
3 weeks until the #XTC2019 Finals! Secure the last ticket to Island Jam ⛵️ https://t.co/r2qbF0bwQN or the last few tickets to #XTC2019, where @ElevianInc@lynq_me @ActivProtectiv will pitch for a chance to win critical infrastructure and investment. 🏆 Email [email protected].
Join us for the #XTC2019 Grand Finale next month on #neckerisland 🔥 Kitesurfing, tech talks & the XTC final stage— 3/31-4/4. Email [email protected] for details.
We’re equally honored to share that Elevian has been selected as @hellotmrc Global Finalists for the #HTChallenge! From 4,500 applications, we are one of the 7 Finalists in the Global Health track pitching at the #HTSummit in Paris on March 14-15th. https://t.co/pXUaBsegYM
Great article from Deep Knowledge Ventures on some of the leading "DeepTech" companies working on therapeutics that target the aging process. https://t.co/TJefWIwGhN #longevity#biotech
“We are honored to be selected as an XTC finalist from a group of amazing startups all working to improve our world. We’re excited to pitch Sir Richard Branson on Necker Island and to share our mission to promote healthy aging.” Mark Allen, Co-Founder & CEO, @ElevianInc
“Each of the 10 companies pitched to a captured audience in the packed room, the judges found it extremely difficult to pick the Top 3...” #XTC2019 Semi-Finals recap 👉🏽 https://t.co/uQjWpQCZ8d
THE XTC TOP 3 of 2019! @Lynq_me, @ElevianInc and @ActivProtectiv are the judges amazing choices who will now go on to #NeckerIsland to pitch to @richardbranson for the #XTC2019 crown. Congratulations and thanks to ALL entrants, judges, sponsors and attendees. 🏆 🥇 🥈 🥉#CES
Ever wondered what is the best company in the GDF11 pathway space? It is @ElevianInc. We are extremely excited to partner with them to combat the age-related diseases at scale. #elevian#insilicomedicine#longevity https://t.co/Ka2X3MfGbk
As #JPM19 draws to a close @ElevianInc, Insilico Medicine partner to discover small molecules that target the #GDF11 pathway to treat age-related diseases. @LaboratoryLiz reports: https://t.co/zB8ibnIgMY
From @BioCentury Extra:
Elevian, AI company Insilico partner to find anti-aging candidates in GDF11 pathway. Details: https://t.co/aQjXGYI1L4 (@LaboratoryLiz )
Related story (and a MUST read):
How Elevian is tackling age-related diseases with GDF11 https://t.co/T5B6vpOhWq
THE XTC TOP 3 of 2019! @Lynq_me, @ElevianInc and @ActivProtectiv are the judges amazing choices who will now go on to #NeckerIsland to pitch to @richardbranson for the #XTC2019 crown. Congratulations and thanks to ALL entrants, judges, sponsors and attendees. 🏆 🥇 🥈 🥉#CES
Last but by no means least, #Healthtech company @ElevianInc develops regenerative medicines to treat age related diseases. Here they are pitching to our panel for their spot at #XTC2019 Final on #NeckerIsland#CES